Alzheimer's disease is a brain disorder which gradually destroys the ability to reason, remember, imagine, and learn. It's different from the mild forgetfulness normally observed in older people. Over the course of the disease, people with Alzheimer's no longer recognize themselves or much about the world around them. Depression, anxiety, and paranoia often accompany these symptoms. Although there is no cure, new treatments help lessen Alzheimer's symptoms and slow its progression.
Alzheimer's is marked by abnormal clumps (called senile plaques) and irregular knots (called neurofibrillary tangles) of brain cells. For reasons not well understood, these plaques and tangles take over healthy brain tissue, devastating the areas of the brain associated with intellectual function.
Over four million people in the United States are living with Alzheimer's disease, which is the most common form of dementia. Experts predict that as baby boomers age, Alzheimer's may affect as many as 14 million people nationwide. Alzheimer's is widespread, affecting 10% or more of those over age 65 and nearly half of those over age 85. Slightly more women than men have Alzheimer's disease. Its increasing prevalence has led epidemiologists to call Alzheimer's "the disease of the century."
While Alzheimer's disease usually affects those over age 65, a rare and aggressive form of Alzheimer's can happen in some people in their 40s and 50s. Alzheimer's disease progresses slowly, taking between three to 18 years to advance from the earliest symptoms to death; the average duration of the disease is eight years. Death results not from the disease itself but from some secondary illness such as pneumonia or urinary tract infection. Right now, treatment of Alzheimer's disease focuses on slowing its progression and coping with its symptoms.
In the early and middle stages of Alzheimer's disease, people with the illness may be painfully aware of their intellectual failings and what is yet to come. At this stage and throughout the course of the illness, it's vitally important to support their mental and emotional well-being with the help of their doctor, social worker, or psychological counselor. Show them love, affection and warmth as they make their journey.
Risk factors and prevention
The following factors increase risk of Alzheimer's disease:
There is no sure-fire way to prevent the onset of Alzheimer's disease. But some preventive treatments (such as estrogen for women) are promising.
Symptoms and Diagnosis
At its onset, Alzheimer's disease is marked by simple forgetfulness, especially of recent events or directions to familiar places. People with Alzheimer's may have personality changes, such as poor impulse control and judgment, distrust, increased stubbornness, and restlessness.
The next stage of the disease is characterized by greater difficulty in doing things that require planning, decision-making, and judgment -- for example, working, balancing a checkbook, or driving a car. Everyday skills such as personal grooming aren't affected, but social withdrawal begins.
Eventually, people with Alzheimer's disease can't do simple tasks of daily living such as eating, bathing, and using the toilet. They may lack interest in personal hygiene and appearance, and lose their usual sexual inhibitions. They may have a hard time recognizing all but their closest daily companions. Communication of all kinds becomes difficult as written and spoken language ability dwindles. Withdrawal from family members begins and the person may become agitated, displaying belligerence and a denial of the illness.
In the last stages of the disease, people with Alzheimer's become bedridden, unable to recognize themselves or their closest family members. They may make small, purposeless movements and communicate only by screaming out occasionally. Essentially, the brain forgets how to live. Death often results from pneumonia and from complications of immobility.
Currently, doctors can't diagnose Alzheimer's disease with 100% certainty until a brain autopsy after the person's death reveals the disease's markers: abnormal clumps and irregular knots of brain cells. So diagnosis of Alzheimer's rests largely on the judgment of physicians experienced in dealing with dementing illnesses. But that judgment has become quite sophisticated. Experts estimate current diagnostic accuracy at around 90%.
Since there are so few treatments for Alzheimer's disease, many of the available therapies attempt to improve the quality of patients' lives, keep them safe, and make caring for them easier. The primary care doctor will closely watch the progress of the person with Alzheimer's to check for medical complications, adjust medications to reach the lowest effective dosage, and assess any changes in drugs used. The doctor may do mental status tests routinely to chart the course of the illness. Support for the main caregiver is also important, and the doctor will help determine at what point the person with Alzheimer's may need professional nursing care outside the home.
Experts are upbeat that new treatments will, in the not-too-distant future, turn the illness into a manageable chronic condition, similar to diabetes or asthma. But progress comes slowly, and to date, there have been no breakthroughs.
Today, the condition is known as Alzheimer's disease (AD), or dementia of the Alzheimer's type (DAT). Some experts are starting to drop the apostrophe "s," calling the condition Alzheimer disease (paralleling the name change from Down's syndrome to Down syndrome), but most authorities continue to use the apostrophe "s" -- Alzheimer's disease.
Alzheimer's disease is sometimes called "pre-senile dementia," and sometimes "senile dementia." In medical jargon, the term "senile" simply means "old." In common usage, however, it denotes a loss of mental faculties. As a result, some people get confused by pre-senile dementia. In common usage, it seems like a contradiction in terms -- dementia before you've lost mental acuity. Actually, in medical jargon, "pre-senile" simply means "younger than 65". Doctors use pre-senile dementia to describe Alzheimer's disease that develops before age 65, and senile dementia for Alzheimer's that develops after 65. Either way -- pre-senile or senile -- it's the same disease.
The term "dementia" may cause problems as well. In common usage, "demented" often implies wildly out of control. In medical jargon, it simply describes a loss of cognitive function. Many people with Alzheimer's develop behavior problems, but some do not.
Cost and research-funding statistics
Experts estimate that Alzheimer's disease costs the United States $80 billion to $100 billion a year in lost productivity, medical care, and personal caretaking.
For people with Alzheimer's cared for at home, the average out-of-pocket cost to family caregivers (excluding lost wages) is $12,500 per year.
For people with Alzheimer's in nursing homes, the average cost is $42,000 per year per person.
The average cost of caring for a person with Alzheimer's from diagnosis until death is $174,000, making Alzheimer's disease the nation's third most costly illness, after heart disease and cancer.
The Alzheimer's disease federal research budget has grown substantially over the past decade, to more than $400 million in 1999. But that figure represents only a small fraction of what the disease costs.
Dramatic 3-D Images Show How Alzheimer's Engulfs
animated images of the impact Alzheimer's has on the brain -
Red colors, in paralimbic and cingulate brain regions, denote areas with greatest gray matter loss, whereas cooler colors (yellow and blue) denote minimal or no gray matter loss. These color-coded maps reveal the spatial pattern of deficits in Alzheimer's disease, and they can help understand how the disease progresses in the human brain. 2 year timespan.
2003 - UCLA and University of Queensland (Australia) neuroscientists
using a powerful new imaging analysis technique have created the first
three-dimensional video maps showing how Alzheimer's disease
systematically engulfs the brains of living patients.
dramatic time-lapse videos show the sequential destruction of brain
areas that control memory function, then emotion and inhibition, and
finally sensation. They also show how the disease spares small brain
regions that control vision and other functions that remain intact in
analysis technique, which detects very fine changes in magnetic
resonance imaging (MRI) brain scans, offers doctors and researchers a
powerful new tool that could speed diagnosis and intervention, and
development of new therapies. Currently, the impact of therapy with
cholinergic drugs and antioxidants is typically assessed only with
cognitive tests; the physical spread of the disease can be evaluated
only in autopsy studies. The findings appear in the Feb. 1 edition of
the peer-reviewed Journal of Neuroscience.
the first time, you can see Alzheimer's disease progressing in living
patients,quot; said Paul Thompson, an assistant professor of neurology at
the David Geffen School of Medicine at UCLA and the study's chief
investigator. quot;We were stunned to see a spreading wave of tissue loss.
Initially confined to memory areas, this loss moved across the brain
like a wild fire, destroying more and more tissue as the disease
type of imaging will allow doctors and researchers to pinpoint where
and how fast the disease is spreading,quot; said Thompson, a researcher at
the UCLA Laboratory of Neuro Imaging. quot;We will urgently apply this
method to reveal how drugs and vaccines combat the wave of brain
damage caused by Alzheimer's disease.quot;
Alzheimer's afflicts 10 percent of people older than 65. Physicians
know that brain lesions, called amyloid plaques and tangles,
accumulate in Alzheimer's patients' brains, causing memory loss,
disorientation and declining ability to cope with everyday life as
brain cells die.
order to track this cell death, the research team scanned 12
Alzheimer's patients and 14 healthy elderly volunteers with MRI brain
scans every three months for two years.
the new image analysis technique, the researchers found that the
Alzheimer's patients lost an average of 5.3 percent of their gray
matter per year. Brain cells were purged even faster in some brain
regions, with patients losing up to 10 percent in memory regions each
year. In contrast, healthy elderly volunteers lost only 0.9 percent of
their brain tissue annually.
time-lapse video based on these scans revealed that the leading edge
of cell loss moved forward like a burning frontier. As patients'
symptoms worsened, the wave of cell loss hit frontal and central brain
regions. These brain areas control patients' inhibitions and emotional
states. After two years, the disease had engulfed virtually the entire
report was provided by
California - Los Angeles
study was supported by the National Library of Medicine, the National
Center for Research Resources, by a Human Brain Project Grant from the
National Institutes of Health, and by GlaxoSmithKline Pharmaceuticals
study's co-authors included Kiralee Hayashi, Michael Hong, David
Herman, David Gravano, Stephanie Dittmer, and Arthur Toga of UCLA;
Greig de Zubicaray, Andrew Janke, Stephen Rose and David Doddrell of
the University of Queensland Center for Magnetic Resonance, Australia;
and James Semple of GlaxoSmithKline Pharmaceuticals, plc, and
Addenbrooke's Hospital, Cambridge, UK.
Famous Alzheimer's Sufferers
- Enid Blyton
- Charles Bronson
- Winston Churchill
- Perry Como
- Alfred Deakin
- Barry Goldwater
- Rita Hayworth
- Charlton Heston
- Former Queen Juliana of the Netherlands
- Iris Murdoch
- Maurice Ravel
- Ronald Reagan
- Sugar Ray Robinson
- Cyrus Vance
- E.B. White
- Harold Wilson
[More on Alzheimers' Disease]